多西环素改善小鼠创伤性脑损伤生存模型结局
该研究为小鼠生存模型实验,将C57BL/6J小鼠分为假手术组、创伤性脑损伤(TBI)组和TBI+多西环素组,用控制性皮质撞击器诱导中度TBI。多西环素组在伤后2小时给予多西环素20 mg/kg,每12小时一次,直至术后第6天。结果显示多西环素组在术后第1天改良神经严重程度评分和握力评分显著改善,术后第3天和第6天共济失调评分显著改善,三组体重变化率无显著差异。作者结论认为多西环素可能通过保护小鼠血脑屏障完整性改善行为和运动功能,鉴于其可及性、可负担性和安全性,有必要在人TBI中研究其作用。
要点
- 小鼠中度TBI后2小时给予多西环素20 mg/kg、每12小时一次至术后第6天,术后第1天改良神经严重程度评分和握力评分显著改善(均p<0.05)。
- 多西环素组术后第3天和第6天共济失调评分显著改善(均p<0.05)。
- 三组体重变化率无显著差异。
- 作者认为有必要在人TBI中研究多西环素的作用。
- 该研究为小鼠生存模型,样本为假手术组15只、TBI组15只、TBI+多西环素组10只。
适用人群与场景
- C57BL/6J小鼠,采用控制性皮质撞击器诱导中度创伤性脑损伤。
处置流程与药物剂量
- TBI+多西环素组在伤后2小时给予多西环素20 mg/kg,每12小时一次,直至术后第6天。
研究设计与关键结果
- 研究类型为小鼠生存模型实验,纳入假手术组15只、TBI组15只、TBI+多西环素组10只。
- 多西环素组术后第1天改良神经严重程度评分和握力评分显著改善(均p<0.05)。
- 多西环素组术后第3天和第6天共济失调评分显著改善(均p<0.05)。
- 三组体重变化率无显著差异。
证据类型、等级与局限
- 证据类型:动物实验(小鼠生存模型)。
- 作者结论认为多西环素可能通过保护小鼠血脑屏障完整性改善行为和运动功能,并认为鉴于多西环素相对普遍的可及性、可负担性和安全性,有必要在人TBI中研究其作用。
对床旁实践的改变
- 该小鼠实验提示多西环素可能改善TBI后神经功能结局,作者认为有必要在人TBI中研究其作用;未提供人体推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Traumatic brain injury (TBI) has significant morbidity and cost implications. Primary treatment modalities aim to decrease intracranial pressure; however, therapies targeting the underlying pathophysiology of a TBI are limited. The TBI-induced microvascular leak and secondary injury are largely due to proteolysis of the blood-brain barrier (BBB) by matrix metalloproteinase-9. We previously observed doxycycline's inhibitory affinity on matrix metalloproteinase-9 resulting in preserved BBB integrity in nonsurvival murine studies. This study sought to determine the effect of doxycycline on functional motor and behavioral outcomes in the setting of a TBI murine survival model.
METHODS: C57BL/6J mice were assigned to a sham, TBI, or TBI with doxycycline arm. A moderate TBI was induced utilizing a controlled cortical impactor. The TBI with doxycycline cohort received a dose of doxycycline (20 mg/kg) 2 hours after injury and every 12 hours until postoperative day (POD) 6. All mice underwent preoperative testing for weight, modified neurological severity score, wire grip, and ataxia analysis (DigiGait). Postoperative testing was performed on POD 1, POD 3, and POD 6 for the same measures. SAS 9.4 was used for comparative analysis.
RESULTS: Fifteen sham mice, 15 TBI mice, and 10 TBI with doxycycline mice were studied. Mice treated with doxycycline had significantly improved modified neurological severity score and wire grip scores at POD 1 (all p < 0.05). Mice treated with doxycycline had significantly improved ataxia scores by POD 3 and POD 6 (all p < 0.05). There was no significant difference in rate of weight change between the three groups.
CONCLUSION: Mice treated with doxycycline following TBI demonstrated improved behavioral and motor function suggesting doxycycline's role in preserving murine BBB integrity. Examining the role of doxycycline in human TBIs is warranted given the relative universal accessibility, affordability, and safety profile of doxycycline.
参考来源
- Malek AJ, Robinson BD, Hitt AR, et al. Doxycycline improves traumatic brain injury outcomes in a murine survival model. J Trauma Acute Care Surg. 2020. PMID: 32467458. doi:10.1097/TA.0000000000002801
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。